FOS and systemic sclerosis: Intriguingly, this effect of SSc-IgG on PAR-1 seems to resemble that of thrombin [17] and engages downstream signalling through the PI3K/mTOR/ERK1/2 pathway and AP-1/c-FOS transcription factor.